We are live on ! Find out more
US Bancorp

US Bancorp Portfolio holdings

AUM $82.4B
1-Year Est. Return 19.69%
This Fund
S&P 500
This Quarter Est. Return
+5.09%
1 Year Est. Return
+19.69%
3 Year Est. Return
+59.6%
5 Year Est. Return
+69.89%
10 Year Est. Return
+246.63%
AUM
$29.2B
AUM Growth
+$1.4B
Cap. Flow
+$144M
Cap. Flow %
0.49%
Top 10 Hldgs %
23.08%
Holding
3,780
New
179
Increased
1,287
Reduced
1,288
Closed
176

Sector Composition

Rank Sector Weight
1 Industrials 12.17%
2 Financials 11.31%
3 Healthcare 10.5%
4 Technology 9.1%
5 Consumer Staples 8.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UIS icon
3476
Unisys
UIS
$238M
$1K ﹤0.01%
77
VEGI icon
3477
iShares MSCI Agriculture Producers ETF
VEGI
$157M
$1K ﹤0.01%
42
VLY icon
3478
Valley National Bancorp
VLY
$8.01B
$1K ﹤0.01%
123
WASH icon
3479
Washington Trust Bancorp
WASH
$717M
$1K ﹤0.01%
25
XES icon
3480
State Street SPDR S&P Oil & Gas Equipment & Services ETF
XES
$382M
$1K ﹤0.01%
5
-35
-88% -$7.57K
XNCR icon
3481
Xencor
XNCR
$1.45B
$1K ﹤0.01%
+53
New +$1.28K
ONIT
3482
Onity Group
ONIT
$327M
$1K ﹤0.01%
12
LGF.A
3483
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
$1K ﹤0.01%
63
+2
+3% +$55
ASXC
3484
DELISTED
Asensus Surgical, Inc.
ASXC
$1K ﹤0.01%
35
CONN
3485
DELISTED
Conn's Inc.
CONN
$1K ﹤0.01%
+134
New +$1.35K
AAIC
3486
DELISTED
Arlington Asset Investment Corp.
AAIC
$1K ﹤0.01%
63
AVTA
3487
DELISTED
Avantax, Inc. Common Stock
AVTA
$1K ﹤0.01%
59
NOVN
3488
DELISTED
Novan, Inc. Common Stock
NOVN
$1K ﹤0.01%
+13
New +$1.35K
SIOX
3489
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$1K ﹤0.01%
6
ZVO
3490
DELISTED
Zovio Inc. Common Stock
ZVO
$1K ﹤0.01%
80
CSOD
3491
DELISTED
Cornerstone OnDemand, Inc.
CSOD
$1K ﹤0.01%
40
+33
+471% +$1.36K
BPY
3492
DELISTED
Brookfield Property Partners L.P. Limited Partnership Units
BPY
$1K ﹤0.01%
28
DZSI
3493
DELISTED
DZS Inc. Common Stock
DZSI
$1K ﹤0.01%
200
SSI
3494
DELISTED
Stage Stores Inc
SSI
$1K ﹤0.01%
345
NVTR
3495
DELISTED
Nuvectra Corporation Common Stock
NVTR
$1K ﹤0.01%
141
-58
-29% -$396
ALDR
3496
DELISTED
Alder Biopharmaceuticals
ALDR
$1K ﹤0.01%
47
+5
+12% +$111
NRE
3497
DELISTED
NorthStar Realty Europe Corp.
NRE
$1K ﹤0.01%
89
EGI
3498
DELISTED
Entre Resources Ltd. Common Shares
EGI
$1K ﹤0.01%
1,500
PETX
3499
DELISTED
Aratana Therapeutics, Inc.
PETX
$1K ﹤0.01%
+200
New +$1.35K
JASNW
3500
DELISTED
Jason Industries, Inc.
JASNW
$1K ﹤0.01%
22,000

Similar funds

US Bancorp's Q1 2017 Portfolio in Review

As of Q1 2017, US Bancorp held 3,780 positions worth $29.2B, up 5% from $27.8B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

US Bancorp's Q1 2017 filing shows 179 new, 1,287 increased, 1,288 reduced and 176 closed positions. Its largest new stake was Bioverativ Inc. Common Stock: 37,511 shares worth $2.04M. The largest sale was Berkshire Hathaway Class A, an estimated $44.4M.

By sector, the portfolio is most concentrated in Industrials at 12% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.

  • US Bancorp's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 37,511 shares worth $2.04M.
  • US Bancorp added most to iShares Core MSCI EAFE ETF in Q1 2017, an estimated $43M increase.
  • US Bancorp's biggest Q1 2017 reduction was Berkshire Hathaway Class A, cutting an estimated $44.4M.
  • US Bancorp fully exited St Jude Medical in Q1 2017, selling an estimated $23.2M.
  • US Bancorp's ten largest holdings make up 23% of its $29.2B portfolio in Q1 2017.
  • US Bancorp opened 179 new positions and closed 176 in Q1 2017.
  • US Bancorp's portfolio value rose 5% quarter-over-quarter to $29.2B.

Based on US Bancorp's 13F filing for Q1 2017, filed 3 May 2017.